Fred Rosenfelt

719 total citations
15 papers, 514 citations indexed

About

Fred Rosenfelt is a scholar working on Pathology and Forensic Medicine, Genetics and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Fred Rosenfelt has authored 15 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 7 papers in Genetics and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Fred Rosenfelt's work include Lymphoma Diagnosis and Treatment (11 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Fred Rosenfelt is often cited by papers focused on Lymphoma Diagnosis and Treatment (11 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Fred Rosenfelt collaborates with scholars based in United States. Fred Rosenfelt's co-authors include Saul A. Rosenberg, Henry S. Kaplan, Jerome S. Burke, F. Roy MacKintosh, Richard T. Hoppe, W. J. Podolsky, Thomas V. Colby, Peter H. Wiernik, Charles H. Redfern and Troy H. Guthrie and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Fred Rosenfelt

15 papers receiving 474 citations

Peers

Fred Rosenfelt
Magdalena Adde Sweden
David Straus United States
Rafael Carrión Spain
Karin Ekström‐Smedby Sweden
David D. W. Twa Canada
Murphy Sb United States
Pamela B. Allen United States
Bodey Gp United States
Irfan Maghfoor Saudi Arabia
Sheila Nair India
Magdalena Adde Sweden
Fred Rosenfelt
Citations per year, relative to Fred Rosenfelt Fred Rosenfelt (= 1×) peers Magdalena Adde

Countries citing papers authored by Fred Rosenfelt

Since Specialization
Citations

This map shows the geographic impact of Fred Rosenfelt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fred Rosenfelt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fred Rosenfelt more than expected).

Fields of papers citing papers by Fred Rosenfelt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fred Rosenfelt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fred Rosenfelt. The network helps show where Fred Rosenfelt may publish in the future.

Co-authorship network of co-authors of Fred Rosenfelt

This figure shows the co-authorship network connecting the top 25 collaborators of Fred Rosenfelt. A scholar is included among the top collaborators of Fred Rosenfelt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fred Rosenfelt. Fred Rosenfelt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Rosenfelt, Fred, Sepehr Rokhsar, Jean Lopategui, et al.. (2015). Concurrent inhibition of MYC and BCL2 is a potentially effective treatment strategy for double hit and triple hit B-cell lymphomas. Leukemia Research. 39(7). 730–738. 27 indexed citations
2.
Figlin, Robert A., et al.. (2015). Literature Review and Profile of Cancer Diseases Among Afghan Refugees in Iran: Referrals in Six Years of Displacement. Medical Science Monitor. 21. 3622–3628. 19 indexed citations
3.
Koç, Omer N., Charles H. Redfern, Peter H. Wiernik, et al.. (2010). A Phase 2 Trial of Immunotherapy With Mitumprotimut-T (Id-KLH) and GM-CSF Following Rituximab in Follicular B-cell Lymphoma. Journal of Immunotherapy. 33(2). 178–184. 7 indexed citations
4.
5.
6.
Redfern, Charles H., Troy H. Guthrie, Alberto Bessudo, et al.. (2006). Phase II Trial of Idiotype Vaccination in Previously Treated Patients With Indolent Non-Hodgkin’s Lymphoma Resulting in Durable Clinical Responses. Journal of Clinical Oncology. 24(19). 3107–3112. 74 indexed citations
7.
8.
Koç, Omer N., Charles H. Redfern, Peter H. Wiernik, et al.. (2005). Extended Follow-Up and Analysis with Central Radiological Review of Patients Receiving FavId® (Id/KLH) Vaccine Following Rituximab.. Blood. 106(11). 772–772. 7 indexed citations
9.
Redfern, Charles H., P H Wiernik, Fred Rosenfelt, et al.. (2004). Successful anti-Id T-cell responses to Id-KLH immunotherapy in B-cell depleted patients with follicular lymphoma (FL) may prolong TTP after rituximab: Phase II trial of FavId. Journal of Clinical Oncology. 22(14_suppl). 2520–2520. 1 indexed citations
10.
Koç, Omer N., Charles H. Redfern, Peter H. Wiernik, et al.. (2004). Id/KLH Vaccine (FavId™) Following Treatment with Rituximab: An Analysis of Response Rate Improvement (RRI) and Time-to-Progression (TTP) in Follicular Lymphoma (FL).. Blood. 104(11). 587–587. 8 indexed citations
11.
Emmanouilides, Christos, Michael Lill, Milhan Telatar, et al.. (2002). Mitoxantrone/Ifosfamide/Etoposide Salvage Regimen with Rituximab for In Vivo Purging in Patients with Relapsed Lymphoma. Clinical Lymphoma. 3(2). 111–116. 6 indexed citations
12.
Thomas, Premi, et al.. (1984). True Histiocytic Lymphoma: An Immunohistochemical and Ultrastructural Study of Two Cases. American Journal of Clinical Pathology. 81(2). 243–248. 15 indexed citations
13.
Rosenfelt, Fred, et al.. (1983). A fatal hyperpyrexial response to bleomycin following prior therapy: a case report and literature review.. PubMed. 55(5-6). 529–31. 10 indexed citations
14.
MacKintosh, F. Roy, Thomas V. Colby, W. J. Podolsky, et al.. (1982). Central nervous system involvement in non-Hodgkin's lymphoma: An analysis of 105 cases. Cancer. 49(3). 586–595. 254 indexed citations
15.
Rosenfelt, Fred & Saul A. Rosenberg. (1980). Diffuse histiocytic lymphoma presenting with gastrointestinal tract lesions the stanford experience. Cancer. 45(8). 2188–2193. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Magdalena Adde Breakdown of academic impact, for papers by David Straus Breakdown of academic impact, for papers by Rafael Carrión Breakdown of academic impact, for papers by Karin Ekström‐Smedby Breakdown of academic impact, for papers by David D. W. Twa Breakdown of academic impact, for papers by Murphy Sb Breakdown of academic impact, for papers by Pamela B. Allen Breakdown of academic impact, for papers by Bodey Gp Breakdown of academic impact, for papers by Irfan Maghfoor Breakdown of academic impact, for papers by Sheila Nair
Rankless by CCL
2026